cyclosporine

FDA Drug Profile — Verkazia, CYCLOSPORINE, Sandimmune, RESTASIS, Restasis MultiDose

Drug Details

Generic Name
cyclosporine
Brand Names
Verkazia, CYCLOSPORINE, Sandimmune, RESTASIS, Restasis MultiDose, Neoral, CEQUA, Cyclosporine
Application Number
NDA214965
Sponsor
Catalent Pharma Solutions, LLC
NDC Codes
22
Dosage Forms
CAPSULE, LIQUID FILLED, EMULSION, INJECTION, SOLUTION, SOLUTION/ DROPS
Routes
OPHTHALMIC, TOPICAL, INTRAVENOUS, ORAL
Active Ingredients
CYCLOSPORINE

Indications and Usage

1 INDICATIONS AND USAGE Verkazia ophthalmic emulsion is indicated for the treatment of vernal keratoconjunctivitis (VKC) in children and adults. Verkazia ophthalmic emulsion is a calcineurin inhibitor immunosuppressant indicated for the treatment of vernal keratoconjunctivitis in children and adults ( 1 )